Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Select category
Search this blog
A Holistic Cure for the Pharmaceutical Industry’s Ailments
Posted on June 17th, 2016 by Betsy Davis in Pharma R&D
Since the turn of the century, the pharmaceutical industry has seen dramatic changes, including dwindling drug pipelines, looming patent expirations and rising costs. (more…)
Biosimilars and Pharmacovigilance: What’s Ahead
Posted on May 20th, 2016 by Betsy Davis in Pharmacovigilance
DNA Magnification
In our first blog in this series, we drew from a recent IMS report to demonstrate the market potential of biosimilars. (more…)
Trail-blazing innovation – Seeking the new blockbuster
Posted on April 11th, 2016 by Ros Cheetham in Pharma R&D
The Holy Grail of the 21st century, at least for pharmaceutical companies, is the one blockbuster drug that will reap rewards of $1Billion+ in peak sales. (more…)
Gender gap, the leaking pipeline of R&D
Posted on January 21st, 2016 by Agnieszka Freda in Pharma R&D
I guess we all worked out that half of the people on this planet are male and the other half are female. If you even sporadically read the papers you must have stumbled upon some sort of article quoting numbers such as (more…)
